Benefits and risks of noninvasive oxygenation strategy in COVID-19: a multicenter, prospective cohort study (COVID-ICU) in 137 h
![Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle.](https://www.ahajournals.org/cms/asset/63891ec5-465a-47e5-86ed-9c3cb7a4efdb/01.res.41.1.9.fp.png)
Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle.
![Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia | Journal of Clinical Oncology Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2017/jco.2017.35.issue-3/jco.2016.68.2914/20171016/images/large/jco.2016.68.2914t2.jpeg)
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia | Journal of Clinical Oncology
![Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment | Blood Cancer Journal Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbcj.2015.75/MediaObjects/41408_2015_Article_BFbcj201575_Fig1_HTML.jpg)
Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment | Blood Cancer Journal
WHITE HOUSE ENVIRONMENTAL JUSTICE ADVISORY COUNCIL MAY 2022 MEETING SUMMARY VIRTUAL PUBLIC MEETING May 11, 2022
![Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia | Journal of Clinical Oncology Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2017/jco.2017.35.issue-3/jco.2016.68.2914/20171016/images/large/jco.2016.68.2914t3.jpeg)
Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia | Journal of Clinical Oncology
WHITE HOUSE ENVIRONMENTAL JUSTICE ADVISORY COUNCIL MAY 2022 MEETING SUMMARY VIRTUAL PUBLIC MEETING May 11, 2022
![PDF) Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia PDF) Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia](https://i1.rgstatic.net/publication/313519153_Long-Term_Follow-Up_of_the_French_Stop_Imatinib_STIM1_Study_in_Patients_With_Chronic_Myeloid_Leukemia/links/5f310c9aa6fdcccc43bb41be/largepreview.png)